Oslo, Norway, 2 December 2019

Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN), is pleased to announce that Alexander Karlsen has been appointed new CFO of Vistin Pharma, and will take up the position from 1 March, 2020.

Mr. Karlsen comes from the position as Country Finance Manager at GE Healthcare Norway, where he has held several senior positions within finance and controlling. From his finance roles, he has extensive experience from the pharmaceutical manufacturing supply chain. He holds a M.Sc. in Business and Economics from the BI Norwegian Business School.

As previously announced, Gunnar Manum has resigned from his CFO position effective 31 December.  Hans Lysheim will step in as interim CFO for the period from 2 January to 28 February. He previously held the position as CFO of NHST Media Group.

*****

For further information, please contact:

Kjell-Erik Nordby
CEO
+47 91 36 42 80
kjell-erik.nordby@vistin.com

Gunnar Manum
CFO
+47 95 17 91 90
gunnar.manum@vistin.com

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin Hydrochloride (API). The Metformin is also available as Direct Compressible lubricated granules. As a solely dedicated European Metformin producer, Vistin Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin Pharma is headquartered in Oslo, Norway, and has highly qualified employees and a dedicated manufacturing facility in Kragerø.